| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2016 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 10,000 | $9.91 | $99,142.00 | - | |
| Jul 27, 2016 | DHR Danaher Corp /de/ | Comas Daniel L | EVP &CFO | Sell | 96,446 | $80.88 | $7,800,331.64 | -20.3% | |
| Jul 26, 2016 | EXAS Exact Sciences Corp | Arora Maneesh | COO | Sell | 7,359 | $14.82 | $109,060.38 | -1.4% | |
| Jul 26, 2016 | EXAS Exact Sciences Corp | Lidgard Graham Peter | Chief Science Officer | Sell | 7,383 | $14.82 | $109,416.06 | -2.9% | |
| Jul 13, 2016 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 15,800 | $9.65 | $152,452.50 | - | |
| Jul 13, 2016 | TMO Thermo Fisher Scientific Inc. | Loewald Thomas W | Senior Vice President | Sell | 8,025 | $155.00 | $1,243,875.00 | -15.4% | |
| Jul 11, 2016 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 10,000 | $9.82 | $98,182.45 | - | |
| Jul 5, 2016 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chief Executive Officer | Sell | 20,000 | $147.69 | $2,953,804.00 | -3.0% | |
| Jul 1, 2016 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chief Executive Officer | Sell | 30,000 | $148.85 | $4,465,638.00 | -2.9% | |
| Jul 1, 2016 | CRL Charles River Laboratories International, Inc. | Massaro George66 | Director | Sell | 3,740 | $83.09 | $310,749.76 | -0.7% | |
| Jul 1, 2016 | CRL Charles River Laboratories International, Inc. | Massaro George66 | Director | Sell | 800 | $83.54 | $66,831.00 | -0.7% | |
| Jul 1, 2016 | EXAS Exact Sciences Corp | Coward D Scott77 | SVP And General Counsel | Sell | 1,644 | $12.28 | $20,188.32 | -6.2% | |
| Jun 30, 2016 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 18,000 | $9.27 | $166,844.02 | - | |
| Jun 29, 2016 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 12,800 | $9.24 | $118,303.50 | - | |
| Jun 27, 2016 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 21,000 | $8.88 | $186,383.50 | - | |
| Jun 24, 2016 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 18,000 | $9.40 | $169,244.75 | - | |
| Jun 22, 2016 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 18,000 | $9.42 | $169,581.00 | - | |
| Jun 21, 2016 | MYGN Myriad Genetics Inc | Ford Alexander | President, Mgl | Sell | 18,637 | $30.87 | $575,384.81 | -15.5% | |
| Jun 20, 2016 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 10,000 | $9.19 | $91,892.00 | - | |
| Jun 16, 2016 | FONR Fonar Corp | Damadian Raymond V | Treasurer | Sell | 2,700 | $19.09 | $51,543.00 | -2.5% | |
| Jun 15, 2016 | TMO Thermo Fisher Scientific Inc. | Shine Daniel P | Senior Vice President | Sell | 6,900 | $148.31 | $1,023,356.00 | -6.8% | |
| Jun 13, 2016 | BIO Bio-Rad Laboratories, Inc. | Hall Shannon | Executive Vice President | Sell | 1,572 | $145.29 | $228,460.86 | -62.3% | |
| Jun 10, 2016 | BIO Bio-Rad Laboratories, Inc. | Schwartz Alice N | Director, 10% Owner | Sell | 7,000 | $147.02 | $1,029,140.00 | -0.4% | |
| Jun 10, 2016 | TMO Thermo Fisher Scientific Inc. | Wilver Peter M | Exec. VP &Chief Admin Officer | Sell | 68,200 | $152.38 | $10,392,633.00 | -29.7% | |
| Jun 9, 2016 | IQV Iqvia Holdings Inc. | Gordon Kevin K51 | EVP And COO | Sell | 24,000 | $66.41 | $1,593,840.00 | -57.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.